Form 4 holding
COO and Executive VP for R&D
RENOVARO BIOSCIENCES INC.
- Security class
- Option to Purchase Common Stock
- Shares / value
- 40,000
- Estimated value
- Report date
- 13 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount